Vitiligo Repigmentation with Melanoma Progression During Pembrolizumab Treatment

Acta Derm Venereol. 2019 Sep 1;99(10):913-914. doi: 10.2340/00015555-3199.
No abstract available

Keywords: melanoma; pembrolizumab; progression; repigmentation; vitiligo.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Disease Progression
  • Female
  • Humans
  • Melanoma / diagnostic imaging
  • Melanoma / drug therapy*
  • Melanoma / secondary*
  • Middle Aged
  • Skin Pigmentation / drug effects*
  • Time Factors
  • Treatment Outcome
  • Uveal Neoplasms / pathology*
  • Vitiligo / chemically induced*
  • Vitiligo / diagnosis
  • Vitiligo / physiopathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab

Supplementary concepts

  • Uveal melanoma